Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).
about
Zinc-chelation contributes to the anti-angiogenic effect of ellagic acid on inhibiting MMP-2 activity, cell migration and tube formationStructural analysis of reactionary dentin formed in response to polymicrobial invasion.Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.Quantitative imaging of disease signatures through radioactive decay signal conversion.Inhibitory effect of blue light emitting diode on migration and invasion of cancer cells.Targeting the T-cell membrane type-1 matrix metalloproteinase-CD44 axis in a transferred type 1 diabetes model in NOD mice.Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.Rigorous incorporation of tautomers, ionization species, and different binding modes into ligand-based and receptor-based 3D-QSAR methods.Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.Molecular determinants of matrix metalloproteinase-12 covalent modification by a photoaffinity probe: insights into activity-based probe development and conformational variability of matrix metalloproteinases.Binding of matrix metalloproteinase inhibitors to extracellular matrix: 3D-QSAR analysis.The advantage of biosensor analysis over enzyme inhibition studies for slow dissociating inhibitors – characterization of hydroxamate-based matrix metalloproteinase-12 inhibitors
P2860
Q28478040-3938FC83-0871-4D81-92C9-277685AE57DEQ30536334-4E2295B8-DEEE-4D04-8B01-0A7EF0A45F5CQ33638905-983BACBB-E74B-463A-AF4D-DD85144E2E6AQ33652126-1F05255B-B243-4004-833C-C698E905C2E9Q33723218-AAC50F07-0548-40E9-8205-DC33AF20F8D4Q34369413-E3FA78AA-BD89-4D16-A7B8-C3EFE80B6D4FQ36252341-35469FF9-99D1-4FDC-887D-D5339793F5FCQ36603586-AE0D52A2-D154-4715-9A2C-549BA3DC241CQ36644577-AE5FE3D6-32E7-4168-9950-7FCF8C8D3230Q38061451-58C54EA8-F63F-474E-A3D7-B124031001F8Q39197180-B68869C8-CA0C-4790-BBBE-3007175DA40FQ39207391-07CA61E3-CEF3-4C82-8526-4F66AAF0F402Q42052886-98666F61-4374-4021-A6B2-E137254C0D0AQ42055721-AF77885C-9A9A-4332-AD96-306F7D281D30Q56945003-6DF9B89C-83A7-4853-87E4-A5A24532AD69
P2860
Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Structural basis for potent sl ...... x metalloproteinase-2 (MMP-2).
@en
Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2
@nl
type
label
Structural basis for potent sl ...... x metalloproteinase-2 (MMP-2).
@en
Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2
@nl
prefLabel
Structural basis for potent sl ...... x metalloproteinase-2 (MMP-2).
@en
Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2
@nl
P2093
P2860
P356
P1476
Structural basis for potent sl ...... x metalloproteinase-2 (MMP-2).
@en
P2093
Gabriel Rosenblum
Oded Kleifeld
Rafael Fridman
Samy O Meroueh
Shahriar Mobashery
Stephen Brown
Steven P Singson
P2860
P304
27009-27015
P356
10.1074/JBC.M301139200
P407
P577
2003-04-04T00:00:00Z